J
Jessica Saunders
Researcher at Monash University
Publications - 13
Citations - 492
Jessica Saunders is an academic researcher from Monash University. The author has contributed to research in topics: Fexinidazole & In vivo. The author has an hindex of 8, co-authored 12 publications receiving 375 citations. Previous affiliations of Jessica Saunders include Monash University, Parkville campus.
Papers
More filters
Journal ArticleDOI
Transformation of Poorly Water-Soluble Drugs into Lipophilic Ionic Liquids Enhances Oral Drug Exposure from Lipid Based Formulations
Yasemin Sahbaz,Hywel David Williams,Tri-Hung Nguyen,Jessica Saunders,Leigh Ford,Susan A. Charman,Peter J. Scammells,Christopher J.H. Porter +7 more
TL;DR: The data suggest that the formation of lipophilic ionic liquids provides a means of increasing dissolved-drug loading in lipid based formulations and thereby promoting the exposure of poorly water-soluble drugs after oral administration.
Journal ArticleDOI
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Susan A. Charman,Alice Andreu,Helena Barker,Scott Blundell,Anna Campbell,Michael Campbell,Gong Chen,Francis C. K. Chiu,Elly Crighton,Kasiram Katneni,Julia Morizzi,Rahul Patil,Thao Pham,Eileen Ryan,Jessica Saunders,David M. Shackleford,Karen L. White,Lisa Almond,Maurice Dickins,Dennis A. Smith,Joerg J. Moehrle,Jeremy N. Burrows,Nada Abla +22 more
TL;DR: This is the first data set to describe in vitro properties for 45 legacy and development anti-malarial drugs and will be a valuable tool for malaria researchers aiming to develop PBPK models for the prediction of human PK properties and/or drug–drug interactions.
Journal ArticleDOI
Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage.
Amanda F. Francisco,Shiromani Jayawardhana,Michael D. Lewis,Karen L. White,David M. Shackleford,Gong Chen,Jessica Saunders,Maria Osuna-Cabello,Kevin D. Read,Susan A. Charman,Eric Chatelain,John M. Kelly +11 more
TL;DR: A systematic study of nitroheterocyclic drug efficacy using highly sensitive bioluminescence imaging of murine infections finds both drugs are more effective at curing chronic infections, judged by treatment duration and therapeutic dose.
Journal ArticleDOI
Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
Maria Terezinha Bahia,Álvaro Fernando da Silva do Nascimento,Ana Lia Mazzeti,Luiz F. Marques,Karolina R. Gonçalves,Ludmilla Walter Reis Mota,Lívia de Figueiredo Diniz,Ivo Santana Caldas,André Talvani,David M. Shackleford,Maria Koltun,Jessica Saunders,Karen L. White,Ivan Scandale,Susan A. Charman,Eric Chatelain +15 more
TL;DR: Pharmacokinetic data suggested that biological efficacy most likely resides with the sulfone metabolite (or subsequent reactive metabolites formed following reduction of the nitro group) following administration of either the sulfoxide or the sulf one and that prolonged plasma exposure over the 24-h dosing window is required to achieve high cure rates.
Journal ArticleDOI
ELQ-300 Prodrugs for Enhanced Delivery and Single-Dose Cure of Malaria
Galen P. Miley,Sovitj Pou,Rolf W. Winter,Aaron Nilsen,Yuexin Li,Jane X. Kelly,Allison M. Stickles,Michael W. Mather,Isaac P. Forquer,April M. Pershing,Karen L. White,David M. Shackleford,Jessica Saunders,Gong Chen,Li Min Ting,Kami Kim,Lev N. Zakharov,Cristina Donini,Jeremy N. Burrows,Akhil B. Vaidya,Susan A. Charman,Michael K. Riscoe,Michael K. Riscoe +22 more
TL;DR: The findings show that the prodrug strategy represents a viable approach to overcome the physicochemical limitations of ELQ-300 to deliver the active drug to the bloodstream at concentrations sufficient for safety and toxicology studies, as well as achieving single-dose cures of patent malaria infections in mice.